This company has been marked as potentially delisted and may not be actively trading. NASDAQ:HUGE FSD Pharma (HUGE) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About FSD Pharma Stock (NASDAQ:HUGE) Get FSD Pharma alerts:Sign Up Key Stats Today's Range$0.23▼$0.2350-Day Range$0.08▼$0.2052-Week Range$0.07▼$1.68VolumeN/AAverage Volume10.14 million shsMarket Capitalization$9.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada. Read More Receive HUGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HUGE Stock News HeadlinesWall Street bets that Musk will take advantage of Trump and already values Tesla at three times the combined value of the top ten European manufacturersNovember 14, 2024 | msn.comWhat the NFL Draft Can Teach Investors About Big PharmaNovember 12, 2024 | wsj.comThis dark force is about to change everythingSomething unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted Cruz calling the White House a “mafia,” and even Trump’s approval rating slipping. But veteran analyst Porter Stansberry says this isn’t really about politics at all. It’s part of a much larger shift he calls The Final Displacement — a historic economic and social realignment already impacting millions of Americans. His new documentary explains what’s driving it and how to prepare before it accelerates further.October 18 at 2:00 AM | Porter & Company (Ad)Tesla extends post-election rally after Wedbush boosts its price targetNovember 11, 2024 | seekingalpha.comZealand Pharma Gains as JPMorgan Flags $10 Billion OpportunityNovember 8, 2024 | bloomberg.comBig Pharma’s Obesity Bonanza Faces New TestsNovember 4, 2024 | msn.comWhy Elon Musk’s Robotaxi Dreams Are PrematureNovember 2, 2024 | finance.yahoo.comTesla: Profitability Increases Should Drive Stock HigherOctober 24, 2024 | seekingalpha.comSee More Headlines HUGE Stock Analysis - Frequently Asked Questions How were FSD Pharma's earnings last quarter? FSD Pharma Inc. (NASDAQ:HUGE) issued its earnings results on Tuesday, November, 14th. The company reported ($0.03) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by $0.11. What other stocks do shareholders of FSD Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that FSD Pharma investors own include Meta Platforms (META), SNDL (SNDL), AMC Entertainment (AMC), Ford Motor (F), NVIDIA (NVDA), Fiverr International (FVRR) and NIO (NIO). Company Calendar Last Earnings11/14/2023Today10/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolNASDAQ:HUGE CIK1771885 Webfsdpharma.com Phone(416) 854-8884FaxN/AEmployees17Year Founded1994Profitability EPS (Trailing Twelve Months)($0.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$17.90 million Net MarginsN/A Pretax MarginN/A Return on Equity-74.06% Return on Assets-55.31% Debt Debt-to-Equity RatioN/A Current Ratio2.34 Quick Ratio2.34 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.33 per share Price / Book0.69Miscellaneous Outstanding Shares40,117,000Free Float36,695,000Market Cap$9.11 million OptionableOptionable Beta0.60 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:HUGE) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredElon’s Optimus to mint new “Musk Millionaires” as soon as Oct 23???Elon Musk may be set to create more "Musk Millionaires" as soon as October 23rd… Because on that day, he's exp...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe “smart money” is piling into one AI power company.Expert Reveals: The #1 Energy Play for 2025 "We're Entering the Greatest Energy Bull Market Since the Indus...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FSD Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
